Puma Biotechnology, Inc. (PBYI)
8.26
-0.14
(-1.61%)
USD |
NASDAQ |
Nov 10, 10:21
Puma Biotechnology Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 192.74M |
| March 31, 2026 | 192.70M |
| December 31, 2025 | 217.67M |
| September 30, 2025 | 202.86M |
| June 30, 2025 | 194.92M |
| March 31, 2025 | 196.18M |
| December 31, 2024 | 214.75M |
| September 30, 2024 | 220.72M |
| June 30, 2024 | 205.00M |
| March 31, 2024 | 214.15M |
| December 31, 2023 | 230.53M |
| September 30, 2023 | 203.60M |
| June 30, 2023 | 200.49M |
| March 31, 2023 | 196.26M |
| December 31, 2022 | 222.06M |
| September 30, 2022 | 198.77M |
| June 30, 2022 | 193.65M |
| March 31, 2022 | 200.68M |
| December 31, 2021 | 226.58M |
| September 30, 2021 | 226.29M |
| June 30, 2021 | 260.00M |
| March 31, 2021 | 258.66M |
| December 31, 2020 | 244.22M |
| September 30, 2020 | 261.70M |
| June 30, 2020 | 263.81M |
| Date | Value |
|---|---|
| March 31, 2020 | 225.53M |
| December 31, 2019 | 234.90M |
| September 30, 2019 | 232.04M |
| June 30, 2019 | 239.86M |
| March 31, 2019 | 331.36M |
| December 31, 2018 | 259.12M |
| September 30, 2018 | 230.72M |
| June 30, 2018 | 227.62M |
| March 31, 2018 | 169.64M |
| December 31, 2017 | 165.52M |
| September 30, 2017 | 181.86M |
| June 30, 2017 | 172.82M |
| March 31, 2017 | 216.62M |
| December 31, 2016 | 252.79M |
| September 30, 2016 | 134.03M |
| June 30, 2016 | 170.89M |
| March 31, 2016 | 205.17M |
| December 31, 2015 | 239.84M |
| September 30, 2015 | 271.62M |
| June 30, 2015 | 302.36M |
| March 31, 2015 | 331.88M |
| December 31, 2014 | 162.76M |
| September 30, 2014 | 172.05M |
| June 30, 2014 | 196.08M |
| March 31, 2014 | 220.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Olema Pharmaceuticals, Inc. | 486.58M |
| Anika Therapeutics, Inc. | 189.60M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Shareholders Equity (Quarterly) | 146.60M |
| Current Ratio | 2.912 |
| Net Debt Paydown Yield | 1.94% |